Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Other financing activities (2016 - 2026)

Bruker filings provide 11 years of Other financing activities readings, the most recent being -$9.4 million for Q4 2025.

  • On a quarterly basis, Other financing activities rose 44.71% to -$9.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.3 million, a 66.67% increase, with the full-year FY2025 number at -$8.3 million, up 66.67% from a year prior.
  • Other financing activities hit -$9.4 million in Q4 2025 for Bruker, down from $6.5 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $10.6 million in Q4 2022 to a low of -$17.0 million in Q4 2024.
  • Median Other financing activities over the past 4 years was -$1.5 million (2023), compared with a mean of -$2.2 million.
  • Biggest five-year swings in Other financing activities: crashed 431.25% in 2024 and later soared 822.22% in 2025.
  • Bruker's Other financing activities stood at $10.6 million in 2022, then tumbled by 130.19% to -$3.2 million in 2023, then crashed by 431.25% to -$17.0 million in 2024, then surged by 44.71% to -$9.4 million in 2025.
  • The last three reported values for Other financing activities were -$9.4 million (Q4 2025), $6.5 million (Q3 2025), and -$4.3 million (Q2 2025) per Business Quant data.